Wealthspire Advisors (Maryland)’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-65
Closed -$2K 1542
2019
Q1
$2K Sell
65
-10
-13% -$311 ﹤0.01% 2182
2018
Q4
$2K Buy
75
+10
+15% +$377 ﹤0.01% 2110
2018
Q3
$3K Hold
65
﹤0.01% 2053
2018
Q2
$3K Hold
65
﹤0.01% 2031
2018
Q1
$3K Hold
65
﹤0.01% 2044
2017
Q4
$2K Buy
+65
New +$2.31K ﹤0.01% 2148
2016
Q2
Sell
-309
Closed -$8K 1782
2016
Q1
$8K Hold
309
﹤0.01% 1235
2015
Q4
$9K Buy
+309
New +$9.91K ﹤0.01% 1221

Other funds holding PAHC

Wealthspire Advisors (Maryland)'s PAHC Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Phibro Animal Health (PAHC) in Q2 2019, closing a stake of 65 shares — an estimated $2K sold.

Wealthspire Advisors (Maryland) first reported a position in PAHC in Q4 2015 and held it in 8 quarters. The position peaked at $9K in Q4 2015. 168 funds tracked by Wall St. Rank hold PAHC as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Phibro Animal Health position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 65 Phibro Animal Health shares in Q2 2019, an estimated $2K.
  • Wealthspire Advisors (Maryland) first reported a position in Phibro Animal Health in Q4 2015 and held it in 8 quarters.
  • Wealthspire Advisors (Maryland)'s Phibro Animal Health position peaked at $9K in Q4 2015.
  • 168 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.